ONESOURCE SPECIALTY PHARMA
|
The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 23.91.
Share Price | ₹1,994.7 | Jul 18,2025 |
Market Cap | ₹22,838.7 Cr | |
Sales-TTM | ₹955.3 Cr | TTM-Standalone Results |
Price/Sales | 23.91x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹22,838.7 Cr] as on Jul 18,2025
(/) Sales [ ₹955.3 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 23.91x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '23.91 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA
PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending to Jul 18,2025 averaged nanx.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of x from fiscal years ending March 2018 to 2022.
- Looking back at the last 0 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in at x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in of x.
How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ONESOURCE SPECIALTY PHARMA | 955.3 | 23.91 | 22,838.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.73 | 406,267.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.09 | 178,672.0 |
CIPLA LTD | 27,547.6 | 4.35 | 119,713.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 10.35 | 119,195.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.22 | 104,999.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.92 | 109,495.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.22 | 98,133.0 |
LUPIN LTD | 22,707.9 | 3.88 | 88,191.1 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.09 | 66,167.8 |
ABBOTT INDIA LTD | 6,409.2 | 11.32 | 72,563.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.09x |
Max industry PS | 23.91x |
Median industry PS | 7.73x |
Average industry PS | 9.01x |
You may also like the below Video Courses